BOLD Q2 2025 Earnings — Boundless Bio, Inc. Revenue & Financial Results | Market Cap Arena

BOLDBoundless Bio, Inc.

$26M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$317,000

Operating Income

-$17M

Net Income

-$16M

EPS (Diluted)

$-0.70

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$179M

Total Liabilities

$57M

Stockholders' Equity

$123M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$317,000	-$265,000	-19.6%
Operating Income	-$17M	-$19M	+12.0%
Net Income	-$16M	-$17M	+7.7%